Commonwealth Fusion Systems’ SPARC tokamak is more than 75% complete. CEO Bob Mumgaard told Reuters on April 21 that the demonstration machine in Devens, Massachusetts will turn on in 2027 — and that CFS plans to move “immediately” into constructing a 400-megawatt commercial power plant in Virginia, which would be the world’s first commercial fusion facility.
That announcement landed two days before MIT Technology Review asked bluntly whether fusion power will ever compete on cost. And it followed TechCrunch reporting “cracks” in the fusion funding boom, with CFS itself among companies selling magnets to generate near-term revenue. One week. One company. Two opposing signals. The fusion sector has entered its accountability phase.
CFS Delivers Its Most Specific Timeline Yet
The 75% figure is the most concrete construction milestone CFS has disclosed publicly. The company — which has raised more than $2 billion, making it the best-funded private fusion venture in the world — has been measured about public timelines since breaking ground at its Devens facility.
Mumgaard’s Reuters interview fills in blanks. SPARC is a compact high-field tokamak designed to demonstrate net energy gain: the machine targets Q > 2, meaning it would produce at least twice as much fusion energy as the energy used to heat the plasma. The device uses high-temperature superconducting (HTS) magnets made from REBCO (rare-earth barium copper oxide) tape — the same technology CFS demonstrated at 20 Tesla in 2021, a genuine technical first. Those magnets generate far stronger fields than conventional superconductors, which allows SPARC to be dramatically smaller than older tokamak designs while confining plasma at fusion-relevant conditions.
The Virginia commercial plant is the bigger story. At 400 megawatts, it would dwarf any fusion device currently operating or under construction. For comparison, ITER — the 35-nation tokamak being built in southern France — is designed to produce 500 MW of fusion power but isn’t expected to generate electricity, has been in development for decades, and has cost tens of billions of euros without yet generating a single plasma. CFS is proposing to go from first plasma to commercial construction in what amounts to months, not decades.
That’s aggressive. Mumgaard acknowledged a “less likely” scenario where Virginia construction begins as early as 2026 — before SPARC even turns on. The implied confidence is that CFS already knows enough about its magnet technology and tokamak design to begin commercial engineering in parallel with demonstration physics.
But construction progress doesn’t equal physics results. SPARC hasn’t produced plasma. Its design targets remain unvalidated by experiment. The 2021 magnet demonstration was significant, but the distance from “strongest fusion magnet” to “working power plant” spans plasma physics validation, tritium fuel handling, heat exhaust engineering, regulatory approval, and grid integration — none of which any private fusion company has completed. The 400MW Virginia commitment is a statement of intent, not a technical result.
Which raises the question that dominated the rest of the week: what will fusion electricity cost?
The Price Question Arrives on Schedule
MIT Technology Review’s April 23 analysis — headlined “Will fusion power get cheap? Don’t count on it.” — represents a shift in how elite technology media covers fusion. Two years ago, the dominant question was whether fusion physics would work at all. Today, the question is whether the economics close.
This matters because fusion’s commercial case depends on competing with alternatives that keep getting cheaper. Solar PV has dropped below $30/MWh in many markets. Utility-scale battery storage costs continue to fall. Even natural gas, despite rising carbon pricing in some jurisdictions, remains cheap on a per-MWh basis. A fusion plant that produces electricity at $150/MWh isn’t a commercial product — it’s a science experiment with a turbine.
No fusion company has published a credible, independently verified levelized cost of electricity (LCOE) estimate. CFS hasn’t. Helion hasn’t. TAE hasn’t. The entire sector is asking investors and policymakers to commit billions based on cost projections derived from devices that don’t exist yet, using supply chains that haven’t been built, operating under regulatory frameworks still being written. That’s not unusual for a pre-commercial technology — but it’s where the scrutiny lands when a sector transitions from “promising” to “show me.”
TechCrunch made a related but distinct observation on April 19. Some companies aren’t waiting for fusion revenue. CFS plans to sell its HTS magnets commercially — to particle accelerators, medical device manufacturers, and industrial applications. Tokamak Energy is doing the same through its TE Magnetics spinoff. These aren’t signs of failure. They’re survival strategies. Fusion development takes a decade or more from first plasma to grid connection. Companies that generate revenue from fusion-adjacent products along the way are likelier to survive the valley between demonstration and commercialization.
But the need for that strategy tells you something about the sector’s financial runway. After several years of record private investment — the Fusion Industry Association tracked over $6 billion flowing into the sector between 2021 and 2025 — capital markets are applying tighter scrutiny. Not skepticism about whether fusion is possible. Skepticism about whether it’s investable on a timeline that returns capital.
General Fusion Tests the IPO Waters
Against that backdrop, General Fusion is signaling a path that no fusion company has yet attempted: a public listing. The Vancouver-based company — backed by Jeff Bezos and pursuing magnetized target fusion (MTF) — spent April on a conference circuit that included major energy sector events, explicitly positioning for a future IPO.
MTF uses pneumatic pistons to compress plasma inside a liquid metal liner — no superconducting magnets, no laser arrays. General Fusion argues that this reliance on existing industrial materials and manufacturing processes reduces cost and engineering complexity relative to tokamak or ICF approaches. The company’s Lawson Machine prototype, under construction in the UK, is the current technical vehicle for proving that claim.
A fusion company going public would be a first. No fusion-focused firm trades on a major exchange today. If General Fusion — or any competitor — reaches a public listing, it marks the sector’s entrance into public capital markets, where quarterly earnings calls and institutional investor expectations replace the patient capital of venture rounds and government grants.
The timing is revealing. General Fusion is positioning for public scrutiny at the exact moment when press coverage questions whether fusion investments deliver returns. That’s either confidence in the Lawson Machine data or a calculation that public markets may be more receptive now — before cost skepticism hardens into consensus — than later. The Lawson Machine results will determine which interpretation holds.
April’s Wider Picture
This week’s stories sit inside a month that’s been unusually active for fusion policy and funding.
ARPA-E committed $135 million to fusion commercialization on April 9 — the agency’s largest concentrated fusion investment. The allocation targets commercialization-stage challenges rather than basic research, consistent with the DOE Office of Fusion’s pivot toward treating fusion as a deployable energy technology.
The UK unveiled a £1.3 billion ($1.7B) National Fusion Energy Strategy the following week — the most specific national funding commitment from any European country. The strategy backs STEP, a prototype fusion power plant planned for West Burton, Nottinghamshire, targeting the early 2040s. At £1.3B, the UK commitment sits between Canada’s $52.5M CAD centre for fusion energy and Japan’s ¥100B+ ($660M) strategic technology designation from November 2025.
Fusion for Energy opened its 2026 Technology Transfer Demonstrator Call on April 15 — a routine but continuing signal that the EU’s ITER-adjacent institutions are working to extract commercial value from fusion R&D, even as ITER itself faces ongoing schedule challenges.
And the IEA featured fusion prominently in its State of Energy Innovation 2026 report, the clearest indication yet that the international energy establishment now tracks fusion alongside solar, wind, and batteries — not as a speculative outlier, but as an energy technology with a credible development trajectory.
Taken together, April 2026 shows a sector where government money, institutional recognition, and commercial ambition are all accelerating — while independent analysis is, for the first time, applying the kind of cost scrutiny that solar and wind faced a decade ago.
What Happens Next
SPARC’s 2027 first plasma is the next inflection point. Whether it achieves Q > 2 determines if the cost conversation gets real inputs or stays theoretical. CFS told the market this week that the machine is getting built. The Virginia plant says they expect results worth a 400MW commercial bet. Now 150 million degrees of plasma has to confirm that confidence.
